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ABSTRACT
PldB, a Putative Phospholipase D Homologue, Mediates Quorum Sensing in
Dictyostelium discoideum Development
by
Yi Chen
Adviser: Derrick Brazill, Ph.D.
Quorum sensing, the ability to measure the local cell density, is required for animal cells
to achieve proper cell growth, differentiation and development. However, because of the
genetic intractability of mammalian cells, we study quorum sensing in the genetically
pliable unicellular eukaryote Dictyostelium discoideum. D. discoideum cells live as
individual cells under vegetative conditions. Starvation sets off development to a
multicellular organism. But cells won’t develop unless enough cells are under starvation
conditions. Approximately 105 cells are needed to form a fruiting body, the final stage of
the development. When starved, cells are able to calculate the concentration of
surrounding starving cells by simultaneously secreting and sensing a glycoprotein named
conditioned medium factor (CMF). A high density of starving cells results in a high level
of CMF, which allows cell aggregation and development. Here, we describe the role of a
putative phospholipase D (PLD) homologue, PldB, in quorum sensing pathways. PldB is
present during early development when quorum sensing is occurring as well as in later
development. pldB¯ cells can aggregate at low cell density. This phenotype is cell
autonomous. Cells overexpressing pldB are unable to aggregate or form fruiting bodies
even at high cell density. These observations imply that PldB is involved in quorum
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sensing. CMF decreases cAMP-stimulated GTPase activity in wild-type cells, but not in
pldB¯ cells, confirming that PldB mediates quorum sensing in the CMF signal pathway.
pldB¯ cells develop faster than wild-type cells, indicating that pldB is involved in the
timing of development. Analysis of early developmental gene expression shows that
cAMP receptor cAR1, required in aggregation, is expressed at higher levels earlier in
pldB¯ cells than in wild-type cells, which may explain the rapid development phenotype
of pldB¯ cells. However, pldB¯ cells have normal chemotactic rate while pldBOE cells do
not chemotax. Cell fractionation and Western blot analysis reveal that PldB protein is
localized to cytoplasmic membrane as well as vesicles. PldB takes effect in quorum
sensing through its phosphatidylcholine hydrolysis product, phosphatidic acid, since
exogenous phosphatidic acid inhibits cell aggregation at low cell density, mimicking the
phenotype of overexpressing pldB. Rapamycin promotes cell aggregation at lower cell
densities for wild-type, pldB¯ and pldBOE cells, implying that TOR may have a role in
quorum sensing downstream of PldB. The knowledge of PLD in quorum sensing will
help us further understand this phenomenon in mammals, which may lead to therapeutic
strategies for tissue/organ repair and cancer treatment.
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CHAPTER 1
Introduction

1.1 Quorum sensing
Quorum sensing, the ability to measure the local cell density, is required for animal cells
to achieve proper cell growth, differentiation and development. Typically, cells secrete
signaling molecules that turn on one or more signaling cascades, which steer the
developmental path of the cells. Quorum sensing mechanisms are present in mammals [1],
Dictyostelium discoideum [2] and bacteria [3].

Bacteria use quorum sensing to co-ordinate their behavior and respond quickly to
changes in environmental conditions in order to survive. These responses include
adaptation to availability of nutrients, defense against other microorganisms, which may
compete for the same nutrients, and the avoidance of toxic compounds potentially
dangerous for the bacteria. Vibrio fischeri, the first bacterium studied for quorum sensing,
can secrete and sense a homoserine lactone molecule and therefore monitor the cell
density [4]. They don’t emit light in the free-living planktonic state. But when they
colonize the light organs of certain luminescent fish or squid and accumulate to a large
number, the high concentration of the homoserine lactone molecule will turn on the
luminescence genes of the bacterium, causing light production.

As to mammalian cells, mice express and secrete an obese protein [1]. The level of
expression of this obese gene signals the size of the adipose depot. A high level signal

2
may act on the central nervous system to inhibit food intake and/or regulate energy
expenditure as part of a homeostatic mechanism to maintain constancy of the adipose
tissue.

Cell-cell communication and group organization are important for bacteria to evade host
defenses and antibiotics in persistent bacterial infections. With the knowledge of quorum
sensing in bacteria, we will be able to develop new therapeutic agents to control the
virulence and treat these infectious diseases through regulating bacterial group behavior,
instead of just killing or stopping the growth of individual bacteria. In mammals,
knowledge of quorum sensing will pave the way for therapeutic strategies for tissue or
organ repair/regeneration to benefit patients with lost limbs, nerve injuries, or damaged
organs. Although promising for quorum sensing research, mammalian cells are
genetically intractable. Hence we study eukaryotic quorum sensing in Dictyostelium
discoideum, which is easily accessible to techniques of molecular cell biology, genetics
and biochemistry.

1.2 A model organism
1935 saw the entry of Dictyostelium discoideum for biological research [5]. For the past
70 years, it has been extensively studied worldwide for intracellular and intercellular
signal transduction, cell motility, differentiation and morphogenesis. A unicellular
eukaryote, D. discoideum provides a system to study cellular and developmental biology
at a level of complexity greater than yeasts, but simpler than plants and animals. A
proteome-based eukaryotic phylogeny shows that D. discoideum diverged from the
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animal-fungal lineage after the plant-animal split [6]. Despite its early divergence,
proteins of D. discoideum are more similar to human orthologues than are those of yeasts
[7]. With its better approximation to the function and regulation of mammalian cells, its
genetic pliability, and its multicellularity during development, D. discoideum makes it
possible to study human disease orthologue proteins in an organism that shares both great
similarity with higher eukaryotes and experimental tractability with yeasts. Moreover, D.
discoideum cells are easy to grow with liquid nutrients. Cell number duplicates in 8-10
hours. Cell development is initiated by simply removing the nutrients and normally
completes within 24 hours. Mutations can affect development without affecting growth.
Mutant strains can be easily selected by inserting a specific drug-resistant cassette into
the genome. With the ease of mutating any gene of interest, its corresponding function or
contribution to a certain biological process can be readily assessed by observing the
changes in phenotype. These characteristics make D. discoideum a good model organism
to work with.

1.3 Life cycle
A social amoeba (cellular slime mold), D. discoideum lives in soil, feeds on bacteria and
reproduces by binary fission. Lack of bacteria or other nutrient sources forces vegetative
individual cells to stop division and develop. This involves cell aggregation,
differentiation

and

morphogenesis.

Through

multiple

stages

of

development,

approximately 105 cells will aggregate to form a fruiting body in 24 hours (Figure 1). A
fruiting body consists of a mass of spore cells on the top of a column of stalk cells. The
20% stalk cells are dead while the 80% spore cells are dormant living cells [8, 9]. Upon
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availability of nutrient sources, the spore cells will germinate and develop back into
individual cells, thus reinitiating the life cycle. In other words, starvation initiates the
transformation from individual cells to a multicellular organism and nutrients reverse the
process. The relatively short and simple life cycle of D. discoideum makes it ideal for
study in development and differentiation. Moreover, an international consortium has
completed the sequencing of D. discoideum genome [6]. D. discoideum has a 34 Mb
haploid genome, which consists of 6 chromosomes encoding approximately 12,500 genes.
It is now easy to identify a gene with its homologue in mammalian species and study its
physiological functions.

Figure 1. Post-aggregation stages of D. discoideum development.
Moving clockwise from lower right, the stages are the loose aggregate, the tight aggregate (mound), the
tipped aggregate, the finger, a slug, and then culmination stages from the Mexican hat stage to the final
fruiting body. This scanning electron micrograph is by R. Lawrence Blanton & Mark Grimson at Texas
Tech. University.
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1.4 cAMP-cAR1-Gα2 signaling
Starving D. discoideum cells have the ability to sense the density of other starving cells.
Without this mechanism, small groups of cells that happen to starve at the same time
would form small, ineffectual fruiting bodies. Normally when the number of starving
cells reaches a certain threshold (~105 cells), they will initiate aggregation by
chemotaxing to extracellular cyclic AMP (cAMP) pulses, which occur every 6 minutes
[10]. Cells have cAMP receptor, cAR1, on the cell surface [11]. This seven transmembrane domain glycoprotein is coupled with a heterotrimeric G protein (Gα2βγ) on
the cytosol side of the plasma membrane [12]. Upon binding of cAMP to cAR1, GTP
binds to Gα2, replacing GDP, and Gα2-GTP separates from βγ subunits [13]. Gα2-GTP
will then activate the downstream guanylyl cyclase, which is needed for activation of
genes required for motility [14] (Figure 2). Gβγ, together with cytosol regulator of
adenylyl cyclase (CRAC) that is recruited to the cell membrane, will activate adenylyl
cyclase (ACA) [15]. cAR1 is evenly distributed along the cell membrane [16]. Yet
CRAC responds to the differential concentrations of cAMP across a cell and binds
rapidly to the membrane side that encounters the highest concentrations of cAMP,
translating the polarity of a cAMP wave into a polar response [15, 17-19]. ACA is a 12
trans-membrane domain protein with 2 large intracellular loops [20]. It increases
intracellular cAMP that is believed to regulate the gene expression needed for
development and releases cAMP into the extracellular space to relay this aggregation
signal to other starving cells [21].
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Figure 2. cAMP signal pathway.
cAMP binds to cell surface receptor cAR1, which is coupled with Gα2βγ protein. GTP replaces GDP on
Gα2 and causes separation of Gα2-GTP from Gβγ. Upon separation, Gα2-GTP and Gβγ activate guanylyl
cyclase and adenylyl cyclase respectively.

1.5 CMF-Gα1 signaling
It has been found that an 80-kDa secreted glycoprotein, conditioned medium factor
(CMF), plays an indispensable role in the activation of cAMP signaling cascade [22-25].
CMF is heat stable and loses <10% of its activity after incubation at 80°C for 25 minutes
[23]. Its glycosylation may help confer the stability. Neither pH (7.0 or below) of the
environment nor light affects the accumulation or the activity threshold of CMF [26].
CMF has a diffusion trait, such that the level of CMF in the vicinity of an isolated
starving cell will be too low to induce the expression of CMF-requiring genes, while the
level in the vicinity of a high density of starving cells will induce the expression of CMFrequiring genes [26]. All these characteristics make CMF a good quorum sensing factor.
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Cells synthesize CMF under vegetative conditions. But only under starvation conditions
do cells secrete and sense CMF [27]. When only a few cells are starving, the CMF level
is low and cells do not respond to cAMP [23]. Once a large number of starving cells
releases a high level of CMF (above 0.3 ng/ml), cells start to chemotax and aggregate
[23]. Therefore, CMF helps coordinate the development of fruiting bodies with
appropriate size by allowing aggregation only when most cells in a given area are
starving, as characterized by a high level of CMF.

CMF exerts control over development by regulating cAMP signaling through cAR1 [24].
With high cell density, and thus a high level of CMF, the cAMP-cAR1-Gα2 signaling
cascade is activated. In the absence of CMF, cAMP can still bind to cAR1, and the
activation of cAR1 can still cause Gα2 to release GDP and bind GTP. However,
activation of downstream adenylyl and guanylyl cyclases is greatly inhibited [28]. This
inhibition of adenylyl and guanylyl cyclases can be removed by a 10-second exposure of
CMF, showing that lack of CMF is the direct cause of inhibition [28]. The presence or
absence of CMF has no effect on the levels of cAMP-cAR1 induced binding of GTP to
membranes [25], arguing that the lack of CMF has no effect on the interaction between
cAR1 and its G protein in vitro. Thus, CMF controls aggregation by regulating cAMP
signaling at a point after G protein activation but before the activations of adenylyl and
guanylyl cyclases.

CMF accomplishes this by controlling the GTPase rate of Gα2 [25]. It has been found
that in cell lysates, approximately 250 molecules of GTP bind to a cell’s membrane in
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response to a pulse of cAMP, regardless of whether CMF is present or absent. After
cAMP stimulation, GTP is hydrolyzed to GDP at a rate of approximately 240 molecules
in 3 minutes in the absence of CMF. However, in the presence of CMF, the rate of GTP
hydrolysis is drastically reduced to approximately 51 molecules in 3 minutes. Since
lysates from cells lacking Gα2 have no cAMP-stimulated GTP binding or hydrolysis,
these results argue that quorum sensing through CMF is accomplished by controlling the
cAMP-stimulated GTPase activity of Gα2.

CMF exerts its effect on cAMP-cAR1-Gα2 signaling through its own G protein signaling
cascade. CMF has its receptor on the cell surface [29], which is coupled with Gα1βγ
protein [30]. After CMF binds to its receptor, Gβγ will be able to activate phospholipase
C (PLC), which in turn regulates the GTPase activity of Gα2 [30]. PLC is stimulated to
produce IP3 and DAG in mammals [31]. This IP3 increases intracellular [Ca2+], which is
known to activate protein kinase C (PKC) [32-34]. DAG also activates PKC directly [35].
CMF has been found to stimulate PKC activity in D. discoideum (unpublished data).
Thus it is reasonable to imagine that PKC is likely downstream to PLC in the CMF-Gα1
pathway (Figure 3).
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Figure 3. CMF signal pathway.
CMF binds to its cell surface receptor, which is coupled with Gα1βγ protein. Gβγ activates downstream
PLC and PKC.

In mammalian cells, PKC regulates downstream phospholipase D (PLD) [36].
Additionally, phosphatidic acid, a product of phosphatidylcholine hydrolysis by PLD, has
been shown to control the GTPase activity of Gα proteins via RGS (regulator of G
protein signaling) proteins [37]. Together, these findings suggest the involvement of PLD
in quorum sensing. In this project, we have a hypothesis that PldB, a homologue of PLD,
mediates quorum sensing in the CMF signal pathway (Figure 4). CMF signal pathway
decreases the GTPase activity of Gα2 and prolongs the lifetime of Gα2-GTP. This keeps
Gα2 in its active form, allowing the activation of adenylyl and guanylyl cyclases, and
makes following chemotaxis and aggregation possible.
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Figure 4. CMF pathway regulates cAMP pathway by decreasing the GTPase activity of Gα2.
We hypothesize that PldB has a negative role in aggregation by increasing the GTPase activity of Gα2 and
lies downstream of phospholipase C in the CMF signal pathway. PldB activity is inhibited upon CMF
binding.
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1.6 Phospholipase D
1.6.1 Definition
A phospholipase is an enzyme that converts phospholipids to fatty acids and other
lipophilic substances. There are four major classes: A, B, C and D. Phospholipase D
(PLD) has two biochemical activities: phosphodiester bond hydrolysis and phospholipid
transphosphatidylation.

As

a

phospholipid

hydrolysis

enzyme,

PLD

cleaves

phosphatidylcholine (PC) to yield phosphatidic acid (PA) and choline, using H2O as an
electron

donor

(Figure

5).

If

alcohol

replaces

H2O,

PLD

can

generate

phosphotidylalcohols. In mammalian cells, there are two classes of PLD activities [38].
One class is phosphoinositide-independent, fatty-acids-activated PLD. No corresponding
cDNA sequences have been reported for this class. The other is phosphoinositidedependent PLD, which is inhibited by free fatty acids. cDNA cloning revealed two
proteins of this class: PLD1 from human HeLa cells and PLD2 from mouse cells. They
share 50% homology.

O
O

CH2

C

O
R

CH2

O

C

O
CH

O

C

R’

CH

CH2

P
O¯

O

C

R’

CH2
H2O

O
O

R
O

O

CH2

CH2

PLD

Phosphatidylcholine

N+(CH3) 3

O
O

P

+

HO

CH2

CH2

N+(CH3) 3

OH

O¯
Phosphatidic Acid

Choline

Figure 5. Phosphatidylcholine hydrolysis.
In the presence of water, PLD cleaves the phosphodiester bond in phosphatidylcholine to produce
phosphatidic acid and choline.
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1.6.2 Structure
The structure of PLD contains two conserved catalytic ‘HKD’ motifs (also known as
conserved region (CR) II and IV, or the transphosphatidylation domains), disruption of
which leads to loss of catalysis function [38] (Figure 6). An ‘IYIENQFF’ motif (CRIII) is
found only in those that have bona fide activity, with a possible role of interacting with
the choline headgroup of PC. CRI and a pleckstrin homology (PH) domain in the
structure interact with phosphoinositol-4,5-biphosphate (PIP2) in the membrane, keeping
the PLD membrane bound and catalytically active [39]. A phox consensus sequence (PX)
motif is reported to mediate protein-protein interactions [40]. The amino-termini of PLDs
are poorly conserved and can tolerate significant modifications, such as fusion to green
fluorescent protein (GFP) without changes in enzyme activity [41, 42]. On the contrary,
the carboxy-termini are relatively well conserved and intolerant to modifications [41, 42].
PLD1 encodes a loop region of 100-150 amino acids at the center of the protein that is
not present in PLD2 or most other PLDs from lower organisms [43, 44]. It is highly
variable and does not seem to affect enzyme activity or localization when modified [45].

Figure 6. Schematic depiction of human PLD1.
Boxes, location of regions of highly conserved sequence or regions unique to PLD1 (loop sequence). P, site
of tyrosine phosphorylation in mPLD2. This figure is from Reference #38.
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1.6.3 Localization and regulation
PLD2 is localized to plasma membrane and only activated by lipids PIP2 and
phosphoinositol-3,4,5-triphosphate (PIP3) [46]. PLD1 is usually found in perinuclear
regions and vesicles [46]. Besides PIP2 and PIP3, PLD1 can also be activated by GTP
binding proteins (ARF and Rho families of GTPases), protein kinase C (PKC), tyrosine
kinases and Ras subfamily of small G proteins [38, 46-49]. PKC activates PLD either
through phosphorylation of PLD itself, or a phosphorylation-independent mechanism
where certain PKC isoenzymes activate PLD [50, 51]. Down-regulation of PKC or
addition of PKC inhibitors impairs receptor mediated PLD activation [52].

1.6.4 Function in mammals
Besides the obvious role in phospholipid turnover and maintenance of the structural
integrity of cellular or intracellular membranes, PLD and its phospholipid hydrolysis
product PA are involved in a multitude of cellular events [53]. PLD1 activity is
implicated in the budding of COPI-coated Golgi vesicles, the formation of nascent
secretory vesicles in the trans-Golgi network, ARF-dependant clathrin coat assembly in
the enodosomal/lysosomal system, and the regulated exocytotic secretion [54]. PLD1 also
plays a role in survival pathways that prevent apoptosis [55]. PLD2 has suggested
functions in actin cytoskeletal rearrangement and receptor-triggered ARF-mediated
endocytic process [54]. Moreover, PA is proposed to mediate the activation of NADPH
oxidase, or the respiratory burst, leading to the release of active oxygen radicals [53].
Thus, determining the roles of PLD in various cellular responses will greatly benefit our
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understanding of the corresponding molecular cell biology and biochemistry, which may
guide us in therapeutic designs for different diseases.

1.6.5 PldB in D. discoideum
In D. discoideum cells, inhibition of PLD activity by butanol leads to aberrant
relocalization of F-actin and impaired phagocytosis and pinocytosis [56]. These effects
by butanol can be reversed by exogenous PA, confirming the effects are caused by
inhibition of PLD activity. These findings suggest that localized PLD activity is essential
for normal actin distribution and endocytosis. In this project, we describe the role of a
putative phospholipase D homologue, PldB, in D. discoideum development.

To identify genes that encode PLD proteins in D. discoideum, a BLAST search is
performed against the database of the Japanese Dictyostelium cDNA project by using the
human phosphatidylcholine-specific PLD1 amino acid sequence as a query. Two
different partial cDNAs are identified. Another BLAST search is performed against the
database of the Dictyostelium Genome project by using the partial cDNAs as queries.
Contigs containing these sequences are identified, yielding large putative open reading
frames for both genes. These genes are named pldA and pldB. pldA is expressed
consistently in both vegetative and developing cells, while pldB is differentially regulated
(unpublished data). pldB is chosen for further study due to its expression pattern.

The pldB gene resides on chromosome 3, is 2,747 nucleotides long with one predicted
intron, and codes for a hypothetical protein of 867 amino acids with a molecular weight
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of ~100-kDa. The translated protein contains the conserved regions found in all PLD1’s
including a PH domain, catalytic region I (CRI), CRII, a loop, CRIII, CRIV, and the Cterminal tail (Figure 7). Overall, the protein shares 32% similarity and 21% identity with
PLD1 from humans. Excluding the N terminus and loop domains, which vary widely
from species to species, PldB has 51% similarity and 34% identity to PLD1 from humans.

Figure 7. Comparison of the predicted amino acid sequences of the catalytic regions of PLDs.
PldB (D. disc), human PLD1 (H. sap1), human PLD2 (H. sap2), and Drosophila melanogaster PLD (D.
mela) are aligned at the three catalytic regions. Amino acid identities are in black boldface type, while
amino acid similarities are in gray. Similarities between PldB and human PLD1: CR II, 89%; CRIII, 90%;
CR IV, 95%.
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1.7 Significance
Quorum sensing is crucial to achieve normal cell growth, differentiation and cell
restoration for mammalian cells. Without the ability to sense the number of cells present,
an organ or tissue will not stop cell division when it reaches the appropriate size nor will
it regenerate cells when damaged. While the genome of mammalian cells is not easy to
manipulate, the single-celled eukaryote D. discoideum gives us easy genetic access to
study quorum sensing. At the initial stage of its transformation to a multicellular
organism, starving cells chemotax toward a common aggregation center using cAMP as
chemoattractant. Previous studies show that cells’ sensing ability comes from a secreted
glycoprotein CMF. CMF regulates cAMP signal pathway and relay by a signaling
cascade involving Gα1βγ protein, PLC and PKC. Here, we demonstrate that a PLD
homologue is involved in the CMF signal pathway, contributing to the further
understanding of quorum sensing signal transduction. The knowledge of quorum sensing
in D. discoideum will give us a framework to examine this phenomenon in mammalian
cells, which can be applied in tissue and organ repair and cancer cell treatment.
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CHAPTER 2
Materials and Methods

2.1 Cell culture
Wild-type cells (Ax2) are grown in axenic HL5 medium (0.5% (w/v) yeast extract, 0.5%
protease peptone, 0.5% thiotone peptone, 1% dextrose, 4.7 mM Na2HPO4, 2.5 mM
KH2PO4, pH 6.5) on a 180 rpm shaking platform at 22°C. pldB¯ cells and pldBOE cells
are grown in the same shaking culture as above containing 10 μg blasticidin/ml and 20 μg
G418/ml respectively. Wild-type and pldB¯ cells are also grown on SM/5 agar plates
with Klebsiella aerogenes. pldBOE cells are also grown on GYP agar plates with the
blasticidin and G418 resistant strain of Escherichia coli.

For development, cells at mid-log phase (2-5×106 cells/ml) are washed with PBM (20
mM KH2PO4, 10 μM CaCl2, 1 mM MgCl2, pH 6.1 with KOH), plated on filter pads at
1×107 cells/pad and incubated at 22°C. For aggregation competent cells, cells are starved
in shaking PBM for 5 hours at 22°C.

2.2 Low cell density aggregation assay
Vegetative cells are collected and washed with PBM. They are then starved as submerged
monolayer culture in a 24-well plate (BD, Franklin Lakes, NJ) at surface densities of
224×103, 112×103, 56×103, 28 ×103, 14 ×103, and 7×103 cells/cm2 in 400 μl PBM, PBM
supplemented with 5 μM, 25 μM, or 50 μM cell permeable phosphatidic acid, 1,2Dioctanoyl-sn-Glycero-3-Phosphate (Avanti, Alabaster, AL), or PBM supplemented with
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1 μM rapamycin (Calbiochem, San Diego, CA). The plate is then incubated at 22°C for
18 hours or longer, and examined with an inverted microscope.

2.3 GTPase assay
Cells are starved in shaking PBM at 107 cells/ml for 5 hours. Cells are then washed twice
with PBM and resuspended in lysis buffer (40 mM HEPES/NaOH, 0.5 mM EDTA, 250
mM sucrose, pH 7.7) to 108 cells/ml. One set of cells is lysed immediately by passage
through a 5 μm nylon filter (GE Water & Process, Trevose, PA) on ice. The other set is
incubated with 1 ng/ml CMF for 30 seconds and then lysed. Both sets of cells are
centrifuged at 14,000× g at 4°C for 3 minutes. The pellets are washed with wash buffer
(10 mM triethanolamine-HCl, pH 7.4, with 0.5 mM EDTA) and resuspended in assay
buffer (10 mM triethanolamine-HCl, pH 7.4) to 108 cells/ml.

1.5 ml tubes on ice are preloaded with 70 μl reaction mixture ( [γ-32P]GTP (0.1
μCi/assay), 2 mM MgCl2, 0.1 mM EGTA, 0.2 mM AMP-PNP, 0.1 mM ATPγS, 10 mM
DTT, 5 mM creatine phosphate, 0.4 mg/ml creatine phosphokinase and 2 mg/ml BSA in
50 mM triethanolamine-HCI, pH 7.4). 10 μM cAMP and 0.01 μM or 50 μM cold GTP
are also preloaded if required.

After 5 minutes preincubation of the reaction mixture at room temperature, the reaction is
initiated by adding 30 μl cell membrane to the 70 μl reaction mixture. The reaction is
carried out for 1 minute and terminated by 500 μl stop buffer (50 mM sodium phosphate
buffer, pH 2.0, with 5% (w/v) activated charcoal). All tubes are then centrifuged at
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14,000× g at 4°C for 5 minutes and 400 μl supernatant is removed and added to 3 ml
scintillation fluid for scintillation counting. All samples are assayed in triplicates.

2.4 Northern blot analysis
Wild-type genomic DNA, pldB upstream primer 5’-CACCATTAGCTTCCCATTGTC-3’
and downstream primer 5’-GGTGATCTTGCATTAGCATCCTC-3’ are used in PCR to
produce pldB probe. The reaction is performed with NovaTaq PCR kit (EMD
Biosciences, San Diego, CA) and contains 30 cycles of 1-minute denaturing at 94°C, 1minute annealing at 55°C and 1-minute extension at 72°C. The PCR product is separated
on a 2% agarose gel and visualized with ethidium bromide. The DNA is extracted and
purified (Millipore, Billerica, MA). 25 ng DNA probe is labeled with

32

P using α-32P

dATP (Perkin Elmer, Wellesley, MA) and DNA labeling system (Invitrogen, Carlsbad,
CA). The labeled probe is then purified by Micro Bio-Spin 6 chromatography column
(BioRad, Hercules, CA).

RNA is isolated from cells starved on filter pads at the times indicated with the Rneasy
mini kit (Qiagen, Valencia, CA) or Trizol reagent (Invitrogen, Carlsbad, CA). 5 μg of
each RNA sample is run on an agarose gel, visualized by ethidium bromide staining, and
transferred to Hybond-N+ nylon membrane (Amersham, Piscataway, NJ). Northern blot
analysis is performed with the following partial gene fragments as DNA probes: pldB
(250bp), cAR1 (710bp), CRAC (616bp), ACA (705bp), and IG7 (368bp). Blots with the
same probe are incubated together in the same hybridization buffer and exposed to film
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for the same length of time in the same film cassette. Densitometry is performed by using
a Molecular Dynamics personal densitometer SI.

2.5 Western blot analysis
1×107 cells at mid-log phase growth are starved on filter pads for 4, 8, 12, 16, 20 and 24
hours. They are then washed into 1.5 ml tubes with 1 ml PBM and centrifuged at 300× g
for 5 minutes. Cell pellets are resuspended in 250 μl ddH2O with 6× SDS-PAGE sample
buffer and heated at 95°C for 3 minutes. 20 μl of each protein sample is loaded into two
separate 10% Tris-HCl polyacrylamide gels (BioRad, Hercules, CA). Gels are run at 80V
for 20 minutes and then 150V till the end. The gel with unstained protein marker is
stained with Coomassie Blue Stain for protein quantity recognition. Proteins in the other
gel with prestained protein marker are transferred to PVDF membrane (GE Healthcare,
Piscataway, NJ). Afterwards, the membrane is blocked with 50 ml blocking buffer (1×
PBS, 0.1% Tween-20, 5% w/v nonfat dry milk) for 1 hour at room temperature on a
shaker. The membrane is then incubated with 1° antibody (custom made by immunizing
a rabbit with the synthetic peptide GCFLIVYKKKKHDEDKPS from amino acids 30 to
47 of PldB and collecting the serum 8 weeks after the second injection and purified by
using the above peptide attached to sepharose beads) at 0.4 μg/ml in 40 ml blocking
buffer for 1 hour, washed with 50 ml PBST (1× PBS + 0.05% Tween-20) 3 times for 5
minutes, incubated with 2° antibody – Anti-rabbit IgG HRP-linked antibody (Cell
Signaling, Danvers, MA) at 10.4 ng/ml in 40 ml blocking buffer for 1 hour and washed
with 50 ml PBST another 3 times for 5 minutes. The membrane is incubated in
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chemiluminescent detection reagent (Pierce, Rockford, IL) for 5 minutes and exposed to
film for 1 minute.

2.6 Transphosphatidylation assay (PLD activity assay)
Cells are incubated at 106 cells/ml in HL5 with [9,10-3H(N)]-Palmitic Acid (Perkin Elmer,
Wellesley, MA) at 5 μCi/ml in a culture dish for 24 hours at room temperature. Cells are
then washed with 5 ml PBM and starved in 10 ml PBM for 5 hours if required. Cells are
resuspended in 5 ml PBM and mixed with 5 ml PBM containing 70 μl butan-1-ol or
tertiary-butanol to achieve 0.7% final concentration, and incubated at room temperature
for 22 minutes. PBM with butanol is removed and 500 μl of ice cold [Methanol:6N HCl
(50:2)] is added. The cells are scraped off the plate and transferred to the first extraction
tube (155 μl of 1N NaCl and 500 μl of ice cold chloroform) on ice. The tubes are then
vortexed for 30 seconds and centrifuged at 14,000× g, 4°C for 2 minutes. The lower
organic phase is transferred to the second extraction tube (350 μl ddH2O, 115 μl methanol
and 115 μl 1N NaCl), which is vortexed for 30 seconds and centrifuged at 14,000× g, 4°C
for 2 minutes. 10 μl of the lower organic phase of the second extraction tube is used to
determine the total CPM of the sample. All the samples are then normalized to the total
CPM. The normalized samples are dried under a flow of nitrogen gas and resuspended in
30 μl of spotting solution (Chloroform:Methanol = 9:1). The tubes are then vortexed and
let sit for 3 minutes. 10 μl of the sample is spotted at a time onto a silica-gel 60Å TLC
plate (Whatman, Florham Park, NJ). The plate is dried at room temperature and placed
into the TLC chamber containing 100 ml mobile phase (the upper organic phase of a
mixture containing [Ethyl Acetate:Isooctane:Glacial Acetic Acid:ddH2O] in the ratio of
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110:50:20:100). The solvent front is allowed to reach the top of the plate. The plate is air
dried and sprayed with 3H enhancer spray (Perkin Elmer, Wellesley, MA) and let dry for
20 minutes. It is then put into a transparent plastic bag and exposed to film for 10 days at
-80°C. The films are scanned by a densitometer and phosphatidylbutanol bands are
quantified by ImageQuant software (GE Healthcare, Piscataway, NJ). Background is
calculated using “local average” in the software.

2.7 Cell fractionation
Wild-type and pldB¯ cells are allowed to develop on filter pads for 16 hours and 20 hours.
Cells are then collected in PBM and sonicated in ice water bath (Misonix, Farmingdale,
NY). Sonication products are centrifuged at 19,000× g, 4°C for 5 minutes to separate
membrane and cytosol fractions. 20 μg protein is boiled for 3 minutes in SDS-PAGE
sample buffer and loaded in a 10% Tris-HCl polyacrylamide gel (BioRad, Hercules, CA),
and Western blot analysis is performed as described above.

2.8 Chemotaxis assay
Cells are starved in shaking PBM at 2×107 cells/ml for 5 hours. All the wells of a 24-well
Transwell plate (Corning, Corning, NY) are preloaded with 600 μl PBM and inserts are
put into half of the wells. 7.5×105 vegetative or starved cells in 100 μl PBM are loaded
into each insert. After 10 minutes, each insert is transferred to a new well. The inserts sit
for another 3 minutes, after which 6 μl 1 mM cAMP is added to half of the wells. The
plate is incubated for 3 hours at 22°C. The inserts are then removed and 3 μl 2 mM
Calcein-AM (Calbiochem, San Diego, CA) is added to all the wells and mixed gently.
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The plate is then incubated at room temperature for 75 minutes, protected from light.
PBM with Calcein-AM is removed afterwards and cells are resuspended in fresh PBM.
Fluorescence of cells is measured by a Typhoon scanner and quantified by ImageQuant
software (GE Healthcare, Piscataway, NJ).
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CHAPTER 3
PldB mediates quorum sensing in the CMF pathway

Quorum sensing is first studied in bacteria [4] and found to be important in cell group
behavior and survival. Later research utilizes cells from higher organisms including
mammals where quorum sensing is involved in cell growth, organization, differentiation
and morphogenesis. Dictyostelium discoideum also uses quorum sensing, and unlike
mammalian cells, D. discoideum is amenable to genetic manipulation. This has made D.
discoideum useful in the field of quorum sensing research.

Typically, a quorum sensing mechanism involves a cell-secreted molecule that cells can
sense. This cell density sensing molecule needs to be stable under diverse environmental
conditions and able to diffuse to a certain range so that cells in a given area can sense the
accumulated amount of the molecule. The amount of this molecule will increase with cell
density. When it reaches a threshold, certain genes will be induced in the cell, which may
lead to physiological changes. In D. discoideum, two such mechanisms have been found
during the early stages of development initiated by starvation [2].

One mechanism is mediated by a molecule called prestarvation factor (PSF). PSF is
synthesized and secreted during growth stage and accumulates in the micro-environment
according to the density of the cells [57]. A 65-kDa glycoprotein, PSF induces expression
of several early developmental genes during late exponential growth, including those
encoding for aggregation stage cAMP receptor (cAR1) and the aggregation-specific form
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of cyclic nucleotide phosphodiesterase [58]. The gene inductive effect of PSF is inhibited
by the presence of bacteria. Production of PSF declines rapidly when cells are shifted to
starvation conditions [58]. These observations indicate that growing cells use PSF to
monitor their own density in relation to their food supply. When appropriate conditions
(cell number high, food approaching depletion) are detected, PSF will induce the
production of gene products needed to initiate cell aggregation and development. When
the food supply is depleted, PSF production declines, chromosomal DNA synthesis
ceases while mitochondrial DNA synthesis continues [59], and a second density sensing
pathway comes into play.

This second cell density sensing mechanism involves an 80-kDa glycoprotein named
conditioned medium factor (CMF). Starving cells simultaneously secrete and sense CMF
so as to coordinate cell aggregation and ensure an effectively-sized fruiting body. Cells
will chemotax to cAMP and aggregate only when a large number of cells are starving in a
given area, signified by a high CMF concentration (> 0.3 ng/ml) [2]. CMF realizes this
control over aggregation by regulating the GTPase activity of Gα2 in the cAMP-cAR1Gα2 signaling cascade [25]. Through its own signal pathway that includes a CMF
receptor, Gα1βγ, PLC and a possible PKC, CMF eventually inhibits Gα2 GTPase activity,
prolongs the lifetime of the cAMP activated Gα2-GTP configuration, and allows cAR1mediated cAMP signal transduction to take place [30]. Thus, downstream adenylyl and
guanylyl cyclases will be activated, genes required for further development will be
induced, and chemotaxis and aggregation will occur (Figure 4).
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This project is focused on the CMF-Gα1 signal pathway with an aim to find out
downstream signaling molecules that lead to the regulation of Gα2 GTPase activity. Here,
we present such a molecule – PldB.

3.1 PldB is a negative regulator of aggregation
CMF based quorum sensing involves PKC and a regulator of Gα GTPase activity. Since
PKC activates PLD in mammalian cells [36] and RGS protein is regulated by PA – a
product of PLD activity [37], it is reasonable to imagine that PLD activity is involved in
CMF signal pathway of quorum sensing. A preliminary low cell density assay is
performed to examine this possibility. The ability of cells to aggregate at different
densities is measured after treating them with butanol, which inhibits PLD function by
blocking its ability to produce phosphatidic acid [60]. The result shows that wild-type
cells starved in the absence of conditioned medium are only able to form aggregates
down to 28×103 cells/cm2. Adding conditioned medium allows aggregation at 7×103
cells/cm2. Butanol (0.1%) in the absence of conditioned medium also allows aggregation
to occur as low as 7×103 cells/cm2, thus mimicking conditioned medium. To ensure that
this effect is due specifically to butanol and not the presence of alcohol, the same
experiment is performed with tertiary-butanol (0.1%), an isomer of butanol, which has no
effect on PLD activity; these cells behave exactly like the untreated cells, aggregating
only down to 28×103 cells/cm2. Therefore, when plated at low cell density, cells treated
with butanol and presumably containing decreased PLD activity respond to starvation as
if they are in the presence of CMF. This result strongly suggests that PLD activity is
involved in quorum sensing.
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Since butanol allows cells to aggregate at low cell density, it is reasonable to believe that
disrupting one or both of the PLD genes would also allow cells to aggregate at low cell
density. To examine this possibility, pldB¯ cells are created by inserting a blasticidin
resistance cassette into the pldB locus by homologous recombination. Genomic
integration and disruption of the pldB gene is confirmed by PCR [60]. Strains exhibiting
proper integration of the disruption construct into the pldB gene are examined for their
ability to aggregate at low cell density. While wild-type cells aggregate down to 28×103
cells/cm2, pldB¯ cells are able to aggregate at 7×103 cells/cm2 (Table 1), similar to the
observation with the addition of butanol to wild-type cells. Thus, disruption of
phosphatidic acid production by butanol or deletion of pldB both allow aggregation at
low cell density. The addition of exogenous CMF had no apparent effect on aggregation
in the pldB¯ cells [60], suggesting that pldB is required by cells to properly respond to
CMF. Therefore, starving cells lacking pldB behave as though they are at high cell
density and are nonresponsive to conditioned medium. This suggests that PldB
suppresses aggregation and is negatively regulated by CMF. Loss of pldB mimics the
presence of CMF.

Since pldB gene activity normally blocks aggregation, it is reasonable to believe that cells
overexpressing pldB should be unable to aggregate at high cell density. To examine this
possibility, strains overexpressing pldB are created by introducing a plasmid-borne copy
of the pldB gene constitutively expressed from the actin 15 promoter into wild-type cells.
RT-PCR [60] and Northern blot analysis (data not shown) are performed on RNA
isolated from vegetative cells to confirm overexpression of pldB. For these pldBOE cells,
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aggregation is inhibited even at 224×103 cells/cm2, the highest cell density examined
(Table 1). Addition of 0.1% butanol is able to partially reverse this inhibition and allow
aggregation at 112×103 cells/cm2 [60], suggesting that the inability to aggregate may be
ameliorated by inhibition of PLD activity. In addition, exogenous CMF is unable to
induce aggregation at a lower cell density [60], corroborating previous results suggesting
that pldB is involved in the cellular response to CMF.

If pldB is a negative regulator of aggregation, then enhancing its activity would preclude
aggregation at higher and higher cell densities; the data show that this is the case.
Likewise, removing its activity would allow cells to aggregate at any density, including
extremely low densities, which the data also show to occur. Taken together, the data
suggest that pldB is involved in quorum sensing as a negative regulator of aggregation
and may lie in the CMF pathway.

Cell type

Presence of aggregates at cell density (×103 cells/cm2) of:
224

112

56

28

14

7

wild-type

+

+

+

+

−

−

pldB¯

+

+

+

+

+

+

pldBOE

−

−

−

−

−

−

Table 1. Ability of wild-type, pldB¯ and pldBOE cells to aggregate at low cell density.
Cells are starved at various cell densities in submerged monolayer culture. The field of cells is then
examined with an inverted microscope at 18 hours. The presence of aggregates is represented by a plus sign,
while the absence of aggregates is represented by a minus sign. These are the representative results of three
separate assays.
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3.2 The ability of pldB¯ cells to aggregate at low cell density is cell
autonomous
pldB¯ cells can aggregate at low cell density while wild-type cells can not. It is possible
that pldB¯ cells improperly secrete a diffusible factor, such as CMF, that allows them to
aggregate at low cell density. If this were true, a small amount of pldB¯ cells, when
mixed with wild-type cells, would secrete enough of the factor to cause the wild-type
cells to aggregate at low cell density. To examine this possibility, wild-type cells and
pldB¯ cells are mixed together at ratios of 1:9, 1:1, and 9:1. Their ability to aggregate at
low cell density is examined (Table 2). The result shows that the addition of 10% pldB¯
cells to wild-type cells does not induce aggregation at low cell density. Conversely, the
addition of 10% wild-type cells to pldB¯ cells does not prevent aggregation at low cell
density. In other words, cells making up the majority in the mixture determine the
phenotype of the mixture. Therefore, the ability of pldB¯ cells to aggregate at low cell
density is not due to a change in cell secretion and is thus cell autonomous.
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Cell type(s) (ratio)

Presence of aggregates at cell density (×103 cells/cm2) of:
224

112

56

28

14

7

wild-type

+

+

+

+

−

−

pldB¯

+

+

+

+

+

+

wild-type: pldB¯ (9:1)

+

+

+

+

−

−

wild-type: pldB¯ (1:1)

+

+

+

+

+

−

wild-type: pldB¯ (1:9)

+

+

+

+

+

+

Table 2. Ability of mixed populations of wild-type and pldB¯ cells to aggregate at low cell density.
Wild-type Ax2 and pldB¯ cells are mixed in different ratios and are starved at various cell densities in
submerged monolayer culture. The field of cells is then examined with an inverted microscope at 18 hours.
The presence of aggregates is represented by a plus sign, while the absence of aggregates is represented by
a minus sign. These are the representative results of three separate assays.
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3.3 PldB lies in the CMF signal pathway
While PldB is clearly involved in quorum sensing, it is possible that this is through a
CMF-independent pathway. CMF is demonstrated to accomplish quorum sensing by
decreasing the GTPase activity of Gα2, keeping Gα2 in the active GTP-bound form [25].
Low cell density aggregation assays have shown that PldB protein is involved in quorum
sensing and possibly in the CMF pathway. Therefore, it is reasonable to presume that
cells without PldB protein will not have a decrease in GTPase activity of Gα2 after
exposure to CMF, since lack of PldB breaks the CMF pathway that regulates the GTPase
activity of Gα2. For cells overexpressing pldB, CMF should not have as much a
decreasing effect on the GTPase activity of Gα2 as it would for wild-type cells, if there is
any. To test this postulation, we perform GTPase activity assays to measure the GTPase
activity of Gα2 under the influence of CMF.

GTP hydrolysis in D. discoideum membranes is caused by a low-affinity GTPase and a
high-affinity GTPase [61, 62]. cAMP binding enhances GTP hydrolysis by stimulating
the high-affinity GTPase, but not the low-affinity GTPase [61]. This high-affinity
GTPase activity is associated with Gα2 [25]. To assess the change in GTPase activity of
Gα2, we need to measure the high-affinity GTPase with cAMP stimulation and presence
of CMF. In the assay, wild-type, pldB¯ and pldBOE cells are starved for 5 hours and lysed
with or without 30-second incubation of CMF. Cell lysates are then added to the reaction
mixture. Half of the samples are stimulated by 10 μM cAMP. [γ-32P] GTP in the mixture
is hydrolyzed by the GTPase activity to GDP and
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Pi.

32

Pi is counted by liquid

scintillation. Total GTPase activity is measured with the presence of 0.01 μM cold GTP.
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Low-affinity GTPase activity is measured with the presence of 50 μM cold GTP. Highaffinity GTPase activity is calculated by subtracting low-affinity GTPase activity from
total GTPase activity. Percent stimulation of GTPase is calculated by comparing highaffinity GTPase with and without cAMP stimulation.

As the results show, wild-type, pldB¯ and pldBOE cells all have an increase in highaffinity GTPase activity with cAMP stimulation (Figure 8). There is no statistically
significant (α=0.05) difference in the cAMP-stimulated percentage of GTPase between
wild-type and pldB¯ cells, or wild-type and pldBOE cells. This demonstrates that wildtype, pldB¯ and pldBOE cells have similar high-affinity GTPase activity after cAMP
stimulation without the presence of CMF. However, with the presence of CMF, wild-type
cells have a statistically significant (α=0.05) decrease in the stimulated percentage of
GTPase activity, while pldB¯ cells and pldBOE cells do not. Thus, wild-type cells respond
to CMF by decreasing the cAMP-stimulated high-affinity GTPase activity of Gα2. Cells
lacking or overexpressing PldB protein appear to be nonresponsive to CMF. These
findings match our postulation. They confirm that PldB protein is required by CMF
signal pathway to regulate the cAMP signal pathway in quorum sensing. Therefore, PldB
mediates quorum sensing in the CMF pathway.
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Percent stimulation of GTPase

35
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−CMF
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pldB¯

pldBOE

Figure 8. Effect of CMF on cAMP-stimulated high-affinity GTPase.
Cell lysates are stimulated with extracellular cAMP with or without the presence of CMF. Percent
stimulation of GTPase is the increase in high-affinity GTPase between samples stimulated with cAMP and
samples without cAMP. Data are presented as mean ± S.E.M. Statistics for the effect of CMF (paired t test;
one-tailed p value): wild-type cells, n=5, p=0.0095; pldB¯ cells, n=3, p=0.2643; pldBOE cells, n=3,
p=0.0650. Statistics for the difference in percent stimulation of GTPase by cAMP (unpaired t test; twotailed p value): wild-type cells vs. pldB¯ cells, p=0.4260; wild-type cells vs. pldBOE cells, p=0.0821.
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3.4 Discussion
In D. discoideum, CMF is demonstrated to be an extracellular quorum sensing signaling
protein that regulates aggregation by decreasing the GTPase activity of Gα2 [25]. This
makes cAMP-mediated signaling possible through Gα2βγ-bound cell surface cAMP
receptor cAR1, which leads to expression of genes needed for cell chemotaxis and
aggregation [25]. This CMF regulation is via a signal pathway that involves Gα1βγ and
phospholipase C [30]. In this project, we identify a gene with sequence similarity to
phospholipase D, pldB, and present evidence to show that it has a role in quorum sensing
pathways.

Cells lacking pldB can aggregate at low cell density, bypassing the requirement for CMF.
This ability is cell autonomous. Cells overexpressing pldB are not able to aggregate at
high cell density, and are thus blocked from any further development. Exogenous CMF
will allow wild-type cells to aggregate at low cell density, but has no effect on pldBOE
cells [60], showing that pldBOE cells are insensitive to CMF. These observations suggest
PldB is a negative regulator of aggregation in the CMF signal pathway. PKC activity has
been detected in D. discoideum [63], though its gene has not been cloned. This PKC
activity is up-regulated by the presence of CMF (unpublished data). In mammalian cells,
PLC activates PKC, which in turn activates PLD. PA, a product of PLD activity,
regulates RGS, which regulates the GTPase activity of G proteins. These observations
lead to our hypothesis: PldB lies downstream of PLC in the CMF signal pathway of
quorum sensing. PldB increases the GTPase activity of Gα2. CMF triggers a decrease in
PldB activity, and therefore GTPase activity of Gα2, allowing cell chemotaxis and
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aggregation to occur. According to this hypothesis, cells lacking PldB have low GTPase
activity of Gα2, as if CMF were present, and are able to aggregate at low cell density.
Cells with high levels of constitutively expressed PldB have sustained high GTPase
activity of Gα2 and insensitivity to CMF. cAMP signaling is therefore blocked.
Obviously, the role of PKC in the CMF pathway needs to be clarified in future research,
as well as the RGS protein that regulates Gα2.

If our hypothesis is true, then the GTPase activity of Gα2 should be insensitive to the
presence of CMF in cells lacking PldB protein. We have shown that this is exactly the
case with the GTPase assay. GTPase activity of Gα2 in cells overexpressing pldB seems
to remain unchanged with CMF. This corroborates the finding that pldBOE cells are
insensitive to CMF in the low cell density assay. All these results fit our hypothesis. This
leads to further investigations to reveal the properties of PldB protein.
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CHAPTER 4
Expression pattern, activity and localization of PldB

Proteins are expressed at different time points of development so as to provide various
functions needed by the cell. Interference with the timing of protein expression may
result in an abnormal development program. The localization of a protein is also
important for proper protein functions. Mislocalization could lead to diverse
physiological aberrations or even halt development altogether. Now that we have
confirmed that PldB protein mediates quorum sensing, we would like to find out the
temporal and spatial characteristics of PldB by examining the RNA and protein
expression patterns, cellular PLD activity and PldB localization in the cell.

4.1 pldB mRNA is detected in developing cells
In order to confirm the developmental regulation of PldB expression, a Northern blot
analysis is performed with total RNA from developing wild-type cells, using a DNA
probe generated from a fragment of pldB. The 2.8 kb pldB mRNA exhibits little or no
expression in vegetative cells (Figure 9). Expression is apparent by 8 hours and peaks by
16 hours. Thus pldB gene is transcribed during development.
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Time of development (hours)
0

4
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16
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24

pldB mRNA
2.6 kb

(2.8 kb)

3.6 kb
2.6 kb

total RNA
(ethidium bromide stain)

1.9 kb
Figure 9. Northern blot of total RNA from developing wild-type cells.
Total RNA is visualized by ethidium bromide staining. Nylon membrane is probed with pldB DNA probe.
RNA sizes are measured by RNA standard run in the same agar gel.
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4.2 PldB protein production roughly parallels mRNA expression
To examine production of the PldB protein, antibodies are raised against a peptide of
PldB. These antibodies are then affinity purified with the same peptide and used to probe
Western blots. To ensure that the antibodies are specific for PldB, antibodies are used on
Western blots of lysates from both wild-type Ax2 cells and pldB¯ cells. Also, to examine
developmental production of PldB, cell lysates from developing cells are used. A band at
approximately 100-kDa appears in the wild-type sample but is absent from the pldB¯
sample (Figure 10), suggesting that the antibodies specifically recognize PldB. PldB is
found in vegetative cells and protein production largely increases during development,
peaking at 20 hours. This pattern roughly parallels that of the pldB mRNA expression.
Thus, PldB is present during early development when quorum sensing is occurring as
well as in later development.

Time of development (hours)
0

wild-type

4

8

12

16

20

24

PldB protein
(~100-kDa)

pldB¯
Figure 10. Western blots of cell lysates from developing wild-type and pldB¯ cells.
PVDF membranes are probed with PldB antibody. Protein quantities are monitored by Coomassie Blue
staining of another gel run simultaneously with the same samples. Protein size is measured by protein
marker run in the same gel.
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4.3 PLD activity of wild-type, pldB knockout and pldB overexpression cells
Western blots show that PldB protein is present throughout development. But whether
PldB functions in cell signaling processes depends on its enzyme activity. Specifically,
PldB is supposed to hydrolyze phosphatidylcholine to form phosphatidic acid and choline,
which includes a phospholipid transphosphatidylation step. Thus, we examine the overall
PLD activity in wild-type, pldB¯ and pldBOE cells with an in vivo transphosphatidylation
assay, also known as a PLD activity assay. In this assay, primary butanol replaces H2O in
phosphatidylcholine hydrolysis, forming metabolically stable phosphatidylbutanol
(Figure 11). Cells are preincubated with [9,10-3H(N)] palmitic acid for 24 hours.
Phospholipids are thus labeled with tritium atoms. The phosphatidylbutanol bands
containing tritium atoms are separated on a thin layer chromatography plate and
visualized on films. Tertiary-butanol can not compete as well with H2O in
phosphatidylcholine hydrolysis. Therefore it is used as a negative control.
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Figure 11. Transphosphatidylation assay.
In the presence of primary butanol, PLD cleaves phosphodiester bond to form phosphatidylbutanol and
choline. Phosphatidylbutanol with tritium atoms is then visualized through thin layer chromatography.
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Quorum sensing happens during early development. Thus we perform the assay on
vegetative and 5-hour starved cells. As is shown previously, D. discoideum has a basal
level of PLD activity [56]. In our assay, under both vegetative and starvation conditions,
pldB¯ cells show lower PLD activity than wild-type cells, while pldBOE cells show higher
PLD activity than wild-type cells (Figure 12, Table 3). The data demonstrate that loss of
PldB causes an overall decrease in cellular PLD activity while overexpression of PldB
causes an overall increase in cellular PLD activity. PldB is thus a true PLD enzyme. PLD
activity is present during quorum sensing and aggregation stages.

wild-type
butan-1-ol

pldBOE

pldB¯

tert-butanol

butan-1-ol

tert-butanol

butan-1-ol

tert-butanol

phosphatidylbutanol

vegetative

phosphatidylbutanol

5-hour starved

Figure 12. Overall PLD activity of wild-type, pldB¯ and pldBOE cells.
In vivo transphosphatidylation assays are performed for vegetative and 5-hour starved cells. Tertiarybutanol is used as a negative control as opposed to butan-1-ol. This is representative of three experiments.

Densitometry Readings (relative to wild-type)
wild-type

pldB¯

pldBOE

vegetative

1

0.85

1.21

5-hour starved

1

0.35

1.39

Table 3. Overall PLD activity of pldB¯ and pldBOE cells relative to wild-type cells.
Phosphatidylbutanol bands in transphosphatidylation assay are scanned by a densitometer and quantified.
Densitometry readings of pldB¯ and pldBOE cells are adjusted relative to that of wild-type cells under
vegetative and starvation conditions.
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4.4 PldB is localized to cellular vesicles and/or cytoplasmic membrane
Protein localization is important for normal enzyme activity and proper cellular functions.
To determine the localization of PldB protein in the cell, total cell lysates are separated
into membrane and cytosol fractions from cells at 16 and 20 hours of development on
filter pads. These are the time points when PldB protein is at its expression peak. Western
blot analysis is performed on both fractions. PldB protein is only observed in the
membrane fractions of wild-type cells at 16-hour and 20-hour of development (Figure 13).
This indicates that PldB protein is localized to cellular vesicles and/or cytoplasmic
membrane.

membrane
wild-type
16hr

20hr

cytosol
pldB¯

16hr

20hr

wild-type
16hr

20hr

pldB¯
16hr

20hr

PldB protein
(~100-kDa)

Figure 13. Western blot of membrane and cytosol fractions of wild-type and pldB¯ cells.
Cell lysates are prepared as described in Materials and Methods and probed with affinity-purified anti-PldB
peptide antibodies.
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4.5 Discussion
As shown by mRNA and protein expression, PldB is present during early development,
when quorum sensing is occurring, as well as in later development. This implies that in
addition to its role in quorum sensing, PldB may have roles in later cell development. In
support of this, we have found that cells lacking PldB are preferentially sorted into the
apical region of a mound when mixed with wild-type cells, indicating they have become
prestalk cells (unpublished data). This is consistent with the later observation that almost
all pldB¯ cells in these mixtures end up in the stalk of the final fruiting body (unpublished
data). This suggests that PldB is involved in cell differentiation and cell sorting during
the mound stage when cells are divided into prestalk cells at the apical tip and prespore
cells at the lower part. The mound stage occurs at 12 hours of development. Our Western
blot shows that PldB is present at this time point. Also, Western blot analysis shows that
PldB protein expression peaks at around 20 hours of development, the culmination stage,
when the spore mass is pulled up the stalk to form a fruiting body. This suggests PldB
may have a role in morphogenesis. Although our pldB knockout cells form similar
fruiting bodies to those of wild-type cells, details in timing and morphology need to be
examined. Total PLD activity is lower in pldB knockout cells and higher in pldB
overexpressing cells. This indicates that PldB is a true PLD enzyme and its activity takes
up a good part of the total PLD activity in D. discoideum. The lack or overexpression of
PldB, as demonstrated by the difference in total PLD activity, causes the divergence in
phenotypes.
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As demonstrated by cell fractionation and Western blot analysis, PldB is localized to
membranes and vesicles. Additionally, GFP-tagged PldB is localized to cytoplasmic
membrane as well as vesicles in cells starved for 5 hours (unpublished data). Cell
organelle staining shows that PldB is co-localized with lysosomes and endosomes, but
not mitochondria (unpublished data). This could be explained by PldB structure.
Sequence analysis shows that PldB contains all of the PLD conserved regions including a
PH domain, CRI to CRIV, a loop, and a C-terminal domain, suggesting a member of the
PLD1 subfamily [38]. PH domains are best known as phospholipid binding domains, but
they have also been shown to be involved in binding to the βγ-subunits of heterotrimeric
G proteins and protein kinase C [64, 65]. In D. discoideum, the PH domains of CRAC
and protein kinase B are believed to be responsible for translocating these proteins to the
plasma membrane during chemotaxis [66-68]. It has been suggested that the selective
localization of such PH domain-containing proteins to the leading edge of the cell is what
allows a directional response to a chemoattractant [69, 70]. Specifically, it is proposed
that the localized activities of phosphatidylinositol 3-kinase and PTEN cause the
accumulation of phosphatidylinositol-(3,4,5)-triphosphate at the leading edge, forming
binding sites for PH domain-containing proteins [66, 71]. Additionally, the PH domain in
PLD1 is suggested to be vital in protein activity for its specific and high affinity binding
to phosphatidylinositol-(4,5)-biphosphate in lipid surfaces [48]. It is therefore feasible
that the PH domain of PldB also allows binding to phospholipids, thus resulting in
localized PLD activity. The PH domain of CRAC binds specifically to PI(3,4,5)P3 and
PI(3,4)P2 [66]. To find out the phosphoinositides that the PH domain of PldB specifically
binds to, a dot blot assay can be performed by incubating PHPldB-eGFP-His fusion protein
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with phosphoinositides spotted on a PVDF membrane, and probing the membrane with
anti-GFP antibodies. Additionally, glutathione-S-transferase (GST) fusion protein
comprising GST and PHPldB can be created to investigate the possibility of PHPldB binding
to Gβγ. Furthermore, visualizing single molecules of green fluorescent protein tagged to
PldB or PHPldB may help reveal the dynamics of PldB localization before and during
chemotaxis with cAMP stimulation. This technique has been demonstrated with CRAC
[72].

In mammalian cells, PLD activity is found in multiple cellular membranes, including the
nuclear envelope, endoplasmic reticulum, Golgi apparatus, transport/secretory vesicles
and plasma membrane [54]. Specifically, PLD1 is enriched significantly in the Golgi
apparatus in the perinuclear region and is also present in cell nuclei [73]. PLD1 associates
closely with membrane fragments of Golgi apparatus and dissociates from the
membranes with inhibition of PA synthesis. This is consistent with its role of vesicle
trafficking from the Golgi apparatus. We show that PldB has similar subcellular
localization in D. discoideum and has a role in quorum sensing. Additionally, loss of PLD
activity in vegetative D. discoideum results in aberrant actin distribution and impaired
endocytosis [56]. This suggests that PLD activity has a role in actin relocalization and
thus phagocytosis and macropinocytosis, which are actin-based processes [74]. Vesicle
trafficking is not only important for vegetative D. discoideum cells, when it mediates the
food intake, but also for developing cells, where it is required for signal secretion and
spore coat formation. This observation raises the possibility that PldB may play a role in
actin organization and vesicle trafficking. In fact, we have found that cells overexpressing
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pldB do not form filopodia under starvation conditions, and therefore can not have proper
chemotaxis or aggregation (unpublished data). This confirms that PldB may regulate
actin polymerization.
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CHAPTER 5
pldB¯ cells develop rapidly

Knowing that PldB mediates quorum sensing and that pldB is expressed during
chemotaxis and aggregation stage as well as later developmental stage, we wonder
whether pldB is required for proper development of the fruiting body. To examine this
possibility, pldB¯ cells are starved on agar and allowed to develop. The resulting fruiting
bodies are relatively normal, with the possibility that pldB¯ fruiting bodies may have
slightly longer stalks than wild-type fruiting bodies (Figure 14).

wild-type

pldB¯

Figure 14. pldB¯ cells form fruiting bodies with slightly elongated stalks.
Wild-type Ax2 and pldB¯ cells are plated with bacteria on agar. As the bacteria are consumed,
development is triggered. Fruiting bodies form after 24 hours. A side view of these fruiting bodies is shown.
Bar, 1 mm.
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To find out whether pldB is involved in the timing of aggregation, the time it takes for
pldB¯ cells to aggregate in submerged culture is examined. Wild-type cell aggregates
appear at 16 hours, while pldB¯ cells form aggregates by 9 hours, demonstrating that they
aggregate more rapidly than wild-type cells (Figure 15).

wild-type

pldB¯

9 hours

16 hours

Figure 15. pldB¯ cells aggregate rapidly in submerged culture.
Cells are starved at 224×103 cells/cm2 in PBM, and photos are taken 9 and 16 hours later. Bar, 1 mm.
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We next examine whether this is a phenomenon associated with submerged cultures by
determining whether pldB¯ cells can develop as rapidly on filter pads. On filter pads,
pldB¯ cells show an accelerated rate of development compared to wild-type cells. pldB¯
cells form aggregates by 4 hours, while wild-type cells show no signs of development. By
6 hours, pldB¯ cells form tight aggregates, whereas wild-type cells only start streaming,
the initial stage of aggregation. pldB¯ cells develop consistently more rapidly, forming
fruiting bodies by 16 hours, 6 hours ahead of the wild-type cells. Thus, loss of pldB
expression allows an earlier initiation of the developmental cycle, leading to early
aggregation and culminating in early fruiting body formation (Figure 16).

There are various reasons that might cause a rapid development phenotype. Here we
examine two possible causes. One is increased rate of chemotaxis, which could make
pldB¯ cells move faster and aggregate sooner. The other is earlier expression of genes
required for chemotaxis and aggregation, which could make pldB¯ cells respond to
external signaling molecules earlier than wild-type cells.
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wild-type

pldB¯

4 hours

6 hours

16 hours

Figure 16. pldB¯ cells develop rapidly on filter pads.
Cells are deposited o filters and allowed to develop. Photos are taken at the indicated times. Bar, 3mm.
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5.1 pldB¯ cells show normal chemotaxis to cAMP while pldBOE cells do not
To determine whether the accelerated development seen in pldB¯ cells is due to altered
chemotaxis, we perform a Transwell chemotaxis assay of wild-type and pldB¯ cells to
extracellular chemoattractant cAMP. pldBOE cells are also included to examine their
chemotactic ability. In this assay, cells are allowed to migrate through a membrane at the
bottom of an insert to the cAMP-containing well, which accommodates the insert. The
chemotactic index is the ratio of the number of cells migrated with cAMP to the number
of cells migrated without cAMP. Therefore, a chemotactic index of 1 indicates that there
is no chemotaxis to cAMP, while a chemotactic index larger than 1 indicates that there is
chemotaxis to cAMP.

Under vegetative conditions, wild-type, pldB¯ and pldBOE cells all have a chemotactic
index around 1 (Figure 17), indicating that there is no chemotaxis to cAMP. This is in
accordance with the phenotype that vegetative cells live as individual cells and do not
aggregate. When cells are starved for 5 hours, wild-type and pldB¯ cells show similar
chemotactic index around 2, indicating that there is chemotaxis to cAMP. However,
pldBOE cells still have a chemotactic index near 1, denoting no chemotaxis to cAMP. The
similarity in chemotactic ability between wild-type and pldB¯ cells suggests that the rapid
development of pldB¯ cells is not caused by an increased rate of chemotaxis.
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3

chemotactic index

2.5

2
vegetative
5-hour starved

1.5

1

0.5

0

wild-type

pldB¯

pldBOE

Figure 17. Chemotactic ability of wild-type, pldB¯ and pldBOE cells.
Vegetative and 5-hour starved cells are used as described in Materials and Methods. Chemotactic index =
(cells migrated with cAMP)/(cells migrated without cAMP). These are the results of three separate assays
with standard deviation.
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5.2 cAR1 is expressed earlier in pldB¯ cells
To determine whether the accelerated development seen in the pldB¯ cells is due to
earlier expression of genes required for development, a series of Northern blots are
performed to examine the expression of three genes required early in development, cAR1
(cAMP receptor on cell surface), CRAC (cytosol regulator of adenylyl cyclase) and ACA
(adenylyl cyclase A), in wild-type and pldB¯ cells. For CRAC and ACA mRNA
expression patterns, we observe no apparent difference in the timing of expression
between wild-type and pldB¯ cells (Figure 18). However, we find that cAR1 is more
highly expressed in pldB¯ cells under vegetative conditions than in wild-type cells
(Figure 19A).

To take a closer look at the expression pattern of cAR1 at the early stage of development,
we isolate total RNA from vegetative cells and cells developed on filter pads at 1, 2, 3, 4,
5, and 6 hours. We confirm that cAR1 mRNA is higher in pldB¯ cells under vegetative
conditions than in wild-type cells (Figure 19B). In addition, cAR1 expression in pldB¯
cells remains consistently higher than in wild-type cells throughout the first 6 hours of
development. cAR1 expression in pldB¯ cells peaks at 3-4 hours of development, while
that of wild-type cells doesn’t peak until 6 hours. Thus cAR1 is expressed earlier and at
higher levels in pldB¯ cells. This suggests that altered cAR1 expression can be one of the
reasons that cause the rapid development phenotype of pldB¯ cells and PldB is involved
in the timing of development.
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Time of development (hours)
0
CRAC
CRAC

4

8

12

16

20

24

wild-type
pldB¯

ACA

wild-type

ACA

pldB¯

Figure 18. Wild-type and pldB¯ cells have similar CRAC and ACA mRNA expressions.
Northern blots of total cellular RNA isolated from wild-type Ax2 cells and pldB¯ cells at 4-hour intervals
after starvation are probed with radiolabeled fragments of the crac gene and aca gene respectively. mRNA
bands in agarose gels are stained with ethidium bromide and used to monitor RNA loading.
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Figure 19. car1 is expressed strongly and early in pldB¯ cells.
Northern blots of total cellular RNA isolated from wild-type Ax2 cells and pldB¯ cells at 4-hour intervals
(A) or 1-hour intervals (B) after starvation are probed with a radiolabeled fragment of the car1 gene. The
same blots are stripped and reprobed with a radiolabeled fragment of the IG7 gene to control for RNA
loading. The densitometry measurements are a ratio of cAR1 to IG7, normalized to the wild-type Ax2
vegetative sample.
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5.3 Discussion
In addition to allowing cells to aggregate in suboptimal density, loss of pldB also
accelerates the developmental program. In both submerged monolayer conditions and on
filter pads, pldB¯ cells aggregate well before wild-type cells. If loss of pldB alters the
chemotactic ability of cells, then it might explain the rapid development phenotype
observed in pldB¯ cells. Here we demonstrate that there is no change in chemotaxis rate
between wild-type and pldB¯ cells at the aggregation stage. Of course, there still could be
changes in other aspects of chemotaxis, such as when cells become chemotactically
active, or how fast cells recover from a chemotactic pulse to cAMP, or how much lateral
movement cells make. Such parameters of chemotaxis can be monitored through
videomicroscopy coupled with Digital Image Analysis Software (DIAS), as depicted
previously [75]. pldBOE cells lack chemotaxis to cAMP under starvation conditions. This
may explain their non-aggregation phenotype.

If the genes required for early development are expressed earlier in pldB¯ cells, then
pldB¯ cells might be able to initiate development earlier and thus have the rapid
development phenotype. Therefore, we examine the expression patterns of the early
development genes cAR1, CRAC and ACA. cAR1 is the cAMP receptor on the cell
surface. It mediates cAMP signaling through its coupled Gα2βγ protein. Upon cAMP
binding, Gα2-GTP separates from Gβγ. Gβγ and CRAC together will activate
downstream adenylyl cyclase – ACA. ACA increases intracellular cAMP, which
regulates expression of genes needed for development and gets released extracellularly to
relay the cAMP chemotaxis signal. There is no apparent difference in the timing of
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expression of CRAC and ACA between wild-type and pldB¯ cells. The seemingly less
expression of ACA and CRAC at 4 hours and 8 hours in pldB¯ cells would only lead to
delayed chemotaxis and aggregation, instead of accelerated development. Thus ACA and
CRAC are not subject to further analysis. Meanwhile, cAR1 is expressed earlier and at
higher levels in pldB¯ cells than in wild-type cells. This suggests that pldB¯ cells may
respond to extracellular cAMP earlier with premature cAR1 on cell surface, and thus
initiate development earlier, causing a rapid development phenotype. The data indicate
that altered cAR1 expression is likely one of the factors that cause the rapid development
of pldB¯ cells, implying that PldB plays a role in the timing of development. Interestingly,
a previous study shows that overexpressing cAR1 at growth and aggregation stages
delays the onset of aggregation by 1-3 hours, though subsequent stages proceed normally
[76]. This is somewhat counterintuitive since cells overexpressing cAR1 are supposed to
respond to cAMP earlier and faster. The authors claim that the constitutively expressed
cAR1 has similar affinity for cAMP to the endogenous one. So the possibility of
exogenous cAR1 having lower affinity is ruled out. Our pldB¯ cells have 2.2 fold more
cAR1 than wild-type at growth stage and 1.1-2.8 fold during early development
(densitometry readings in Figure 19). While in their study, cAR1 is constitutively
overexpressed at 7-40 times over growth stage and 3-5 fold over aggregation stage. This
might cause constant adaptation of the cAR1-ACA pathway, as has been suggested
recently [77]. This adaptation may explain the aggregation delay phenotype.

Besides pldB¯ cells, Gα1¯ cells or drug treatments, such as addition of PKC activators,
also cause aggregation at low cell density ([30]; unpublished data). But they do not have
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the rapid development phenotype. This argues that pldB may also play a role in
aggregation or development that is outside of CMF signal pathway. It has been reported
that overexpressing DdPK2 or DdPK3, which encode catalytic subunits of protein kinase
A (PKA), will cause rapid development in D. discoideum cells [78, 79]. PKA is crucial at
all stages of D. discoideum development. Knocking out the catalytic subunit of PKA will
preclude transcription of genes required for early development, such as acaA, pdiA, carA,
and make cells non-aggregative [80]. It is easy to understand that overexpressing the
catalytic subunits of PKA will cause higher PKA activity, which may lead to higher and
earlier expression of developmental genes, and thus the rapid development phenotype.
Since PKA regulates PLD activity in mammalian cells [81-84], it is conceivable that
PKA may regulate PldB or vice versa in D. discoideum. If PKA inhibits PldB activity,
then overexpressing PKA activity will mimic lack of PldB, thus leading to a rapid
development phenotype. Or if PldB inhibits PKA activity, then overexpressing PldB will
nullify PKA activity, thus prevent expression of early developmental genes, resulting in a
non-aggregation phenotype. These hypotheses can be tested by measuring PLD activity
with PKA inhibitors and activators or PKA knockout and overexpressing strains, and
measuring PKA activity with butan-1-ol to inhibit PLD activity or pldB¯ and pldBOE cells.

During D. discoideum chemotaxis, a cAMP phosphodiesterase (PDE) is secreted to
extracellular space to reduce cAMP, terminate cAMP receptor adaptation, and prepare
the cells for a new encounter with cAMP [85]. Overexpression of PDE leads to rapid
aggregation, presumably because the cells spend less time in an adapted state, though
development is arrested at mound stage [86]. Additionally, disruption of a gene that

58
contains a PDE sequence causes precocious accumulation of intracellular cAMP at
vegetative and early development stages, and thus a rapid development phenotype [87].
In mammalian cells, Ca2+-stimulated intracellular redistribution of cAMP-specific
phosphodiesterase is dependent on the PLD-mediated generation of phosphatidic acid
[88]. These observations suggest a possibility that PldB protein might regulate PDE in D.
discoideum. Assessing the PDE activity and its localization and secretion with pldB¯ and
pldBOE cells may reveal the connection.

Finally, EDTA-resistant cohesiveness is stronger in D. discoideum cells with rapid
aggregation [89]. In human patients with myeloid leukemia, depression of glycosylphosphatidylinositol-specific PLD activity can increase the adhesion rate of bone marrow
mononuclear cells [90]. These facts elicit the possibility that PldB might have an
additional role in cell-cell adhesion in D. discoideum. This can be tested with a cell
cohesion assay, which measures the number of non-aggregated and aggregated cells from
a shaking flask of starving cells at different time points [91].
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CHAPTER 6
Downstream signaling of PldB

We have hitherto shown that PldB mediates quorum sensing by suppressing aggregation.
Cells lacking pldB can aggregate at low cell densities and have accelerated development.
Cells overexpressing pldB can not chemotax to extracellular cAMP or form aggregates at
even high cell densities. PldB takes effect in the CMF signal pathway that regulates the
GTPase activity of Gα2. Naturally, we wonder what could be the downstream signaling
molecules to PldB. Here we present evidence for two of these downstream molecules:
phosphatidic acid (PA) and target of rapamycin (TOR).

The principal PLD activity in all organisms is to hydrolyze phosphatidylcholine to create
PA and choline. PA has been shown to be a signaling molecule in mammalian cells [92].
It is very likely that PldB uses PA to implement its functions in D. discoideum.

The target of rapamycin (TOR) is a serine/threonine kinase highly conserved from yeasts
to mammals that controls cell growth in response to nutrients [93]. As the name implies,
the immunosuppressant rapamycin inhibits TOR activity by binding to the FRB region in
the C terminus of TOR proteins [94]. In mammalian cells, mammalian target of
rapamycin (mTOR) integrates input from multiple upstream pathways, including growth
factors, nutrients and energy [95]. One mode of mTOR regulation by growth factor
involves PLD1 and PA [96, 97]. The growth factor activates PLD1 via the small GTPase,
Cdc42 (a Rho family protein), causing an intracellular increase of PA [97]. PA directly
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interacts with the domain in mTOR that is targeted by rapamycin, and activates mTOR
[96]. Recent studies in eukaryotic cells have identified two distinct TOR complexes,
TORC1 and TORC2, which phosphorylate different substrates and have distinct
physiological functions [98]. In D. discoideum cells, a TOR-containing complex that is
related to the TORC2 of Saccharomyces cerevisiae regulates both chemotaxis and signal
relay [75]. Three knockout strains of three distinct components of the complex all have
non-aggregation phenotypes. The reasons are found to be loss of ACA activation and
reduced chemotaxis rate with loss of cell polarity. This demonstrates that TOR is present
during chemotaxis and aggregation stage and it plays a significant role in the process.
Together, these observations imply that TOR might have a role in quorum sensing.
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6.1 Phosphatidic acid inhibits cell aggregation
To determine whether PA may serve as a downstream messenger of PldB in quorum
sensing pathways, we perform low cell density assays with exogenous cell permeable
phosphatidic acid. Both wild-type and pldB¯ cells show aggregation inhibition with
various concentrations of PA (Table 4), mimicking the phenotype of pldBOE cells.
Obviously, overexpressing pldB will raise the level of intracellular PA, thus having an
effect on cell aggregation similar to that of adding exogenous PA. As could be predicted,
PA has more of an effect on wild-type cells than on pldB¯ cells at threshold levels. This
implies that PA may be the downstream signal of PldB in the CMF signal pathway.

Cell type and
treatment

Presence of aggregates at cell density (×103 cells/cm2) of:
224
112
56
28
14
7

Ax2

+

+

+

+

−

−

Ax2 + 5 μM PA

+

+

−

−

−

−

Ax2 + 25 μM PA

+

−

−

−

−

−

Ax2 + 50 μM PA

−

−

−

−

−

−

pldB¯

+

+

+

+

+

+

pldB¯ + 5 μM PA

+

+

+

+

+

−

pldB¯ + 25 μM PA

+

−

−

−

−

−

pldB¯ + 50 μM PA

−

−

−

−

−

−

Table 4. Effect of phosphatidic acid (PA) on low cell density aggregation.
Wild-type Ax2 cells and pldB¯ cells are starved at various cell densities in submerged monolayer culture in
the absence or presence of PA. The field of cells is then examined with an inverted microscope at 22 hours.
The presence of aggregates is represented by a plus sign, while the absence of aggregates is represented by
a minus sign. These are the representative results of three separate assays.
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6.2 Rapamycin promotes cell aggregation
To examine the possibility of TOR being involved in quorum sensing, a low cell density
assay is performed with rapamycin. The results demonstrate that rapamycin promotes cell
aggregation at lower cell densities for all cell types tested (Table 5). Rapamycin in wildtype cells mimics loss of pldB, making cells aggregate at 14×103 cells/cm2. This suggests
that TOR is involved in quorum sensing and it could be upstream or downstream of PldB.
However, rapamycin also has an aggregation-promoting effect on pldB¯ and pldBOE cells.
This implies that TOR is actually downstream of PldB.

Cell type and treatment

Presence of aggregates at cell density (×103 cells/cm2) of:

112

56

28

14

7

3.5

Ax2

+

+

+

−

−

−

Ax2 + 1 μM rapamycin

+

+

+

+

−

−

pldB¯

+

+

+

+

+

−

pldB¯ + 1 μM rapamycin

+

+

+

+

+

+

pldBOE

−

−

−

−

−

−

pldBOE + 1 μM rapamycin

+

−

−

−

−

−

Table 5. Effect of rapamycin on low-cell-density aggregation.
Wild-type Ax2 cells, pldB¯ cells and pldBOE cells are starved at various cell densities in submerged
monolayer culture in the absence or presence of rapamycin. The field of cells is then examined with an
inverted microscope at 47 hours. The presence of aggregates is represented by a plus sign, while the
absence of aggregates is represented by a minus sign. These are the representative results of three separate
assays.
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6.3 Discussion
The enzyme activity of PLD is the hydrolysis of phosphatidylcholine to phosphatidic acid
(PA) and choline. PA has been identified as a second messenger in cell signal
transduction [92]. It is then natural to imagine that PA has a role in quorum sensing as a
product of PldB activity. Low cell density assays are performed to investigate this
possibility with a series of increasing PA concentrations. The results confirm the
involvement of PA in quorum sensing. Exogenous PA makes cells unable to aggregate at
high cell densities, just as overexpressing pldB will do. Obviously, overexpressing pldB
will increase PA production, which is mimicked by adding exogenous PA. The data are
consistent with PldB taking effect in the CMF signal pathway through PA production.

In view of PA regulating TOR in mammalian cells and the requirement of a TOR
complex for aggregation in D. discoideum, we wonder whether TOR has a role in quorum
sensing. Again, low cell density assays are performed with rapamycin to inhibit TOR
activity. Addition of rapamycin causes wild-type, pldB¯ and pldBOE cells to aggregate at
lower cell densities than they would without rapamycin. This phenotype is similar to that
of knocking out pldB gene. This indicates TOR is involved in quorum sensing and
probably downstream of PldB, and therefore PA.

With these data, it is reasonable to come up with this hypothesis: PA activates TOR, and
TOR eventually increases GTPase activity of Gα2. Since PA and rapamycin both interact
with the same domain in TOR, exogenous rapamycin will compete with endogenous PA
in binding to TOR. TOR is then less activated, thus GTPase activity of Gα2 is lower. Gα2
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is preferentially kept at active GTP-bound form, and chemotaxis and aggregation are
allowed to occur. Conversely, overexpressing PldB results in elevated PA production,
which makes TOR highly activated. Consequently, GTPase activity of Gα2 is high. Gα2
is preferentially kept at inactive GDP-bound form, and chemotaxis and aggregation are
not allowed to occur.

It is interesting to notice that for the mammalian TOR-containing multiprotein complexes,
TORC1 is sensitive to rapamycin while TORC2 is not [99]. Correspondingly, a putative
TORC1 is present during growth of D. discoideum [75]. Rapamycin inhibits cell growth,
and knocking out the TOR gene seems to be lethal to cells. Yet TORC2, mutation of
whose components results in non-aggregation phenotype, is rapamycin-insensitive,
because the signaling pathways that are genetically controlled by TORC2 are not
inhibited by rapamycin [75]. Mutant strains of TORC2 do not have growth defects [75].
This implies that a TORC1 controls the growth of D. discoideum while a TORC2 plays a
role during development. Our data demonstrate that the TOR involved in quorum sensing
is sensitive to rapamycin. Suppressing its activity leads to aggregation at lower densities,
instead of non-aggregation. Thus this TOR complex doesn’t seem to be TORC2, but
TORC1. This implies that the TORC1 controlling cell growth may still be available
during development, at least the initial quorum sensing stage. If so, then both TORC1 and
TORC2 are present during the transition stage from growth to development. To
determine whether TORC1 and TORC2 are directly involved in the CMF quorum sensing
pathway, performing low cell density assay and GTPase assay of Gα2 on TORC2 mutant
strains and TORC1 overexpressing strains will be helpful.
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On the other hand, PA is a regulator of RGS (regulator of G protein) activity. Specifically,
mammalian RGS4 is inhibited by PA [37]. RGS proteins act as GTPase activating
proteins for heterotrimeric G proteins. The controlling effect of CMF on GTPase activity
of Gα2 is indirect and involves a G protein-coupled signaling cascade. An RGS protein is
most likely directly responsible for controlling the GTPase. This RGS protein could be
regulated by PA produced by PldB. Therefore, PldB, through localization provided by its
PH domain, could be involved in localized regulation of Gα2, the G protein mediating
cAMP chemotaxis. Given that G proteins in chemotaxing cells are evenly distributed
along the membrane [100], localized control of G protein activity could help to influence
the polarization of a chemotaxing cell. Specifically, a gene encoding RGS domaincontaining protein kinase (RCK1) has been identified in D. discoideum [101]. RCK1 is
preferentially expressed at the aggregation stage of development. rck1 null cells
chemotax approximately 50% faster than wild-type cells, while overexpression of wildtype RCK1 reduces chemotaxis speed by approximately 40%. This suggests that RCK1
plays a negative regulatory role in chemotaxis and is consistent with a putative function
of activating GTPase activity of Gα2. Upon cAMP stimulation, RCK1 transiently
translocates to the membrane region with similar kinetics of membrane localization of the
PH domain-containing proteins. Further genetic evidence suggests that Gα2 may directly
interact with RCK1. This report is intriguing in that this RGS domain-containing protein
kinase can possibly be involved in quorum sensing and directly regulate the GTPase
activity of Gα2. It would be interesting to examine the role of this RGS protein in quorum
sensing with low cell density assay and GTPase assay of Gα2, identify its substrate with
GST fusion protein technique, and deduce its connection with PA and TOR.
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CHAPTER 7
Summary

We present evidence to show that a putative PLD homologue, PldB, mediates quorum
sensing in Dictyostelium discoideum development by negatively regulating cell
aggregation. Cells lacking pldB can aggregate at low cell density. This phenotype is cell
autonomous. Cells overexpressing pldB are unable to aggregate even at high cell density.
PldB functions in the CMF signal pathway that regulates the cAMP signal pathway by
decreasing the cAMP-stimulated GTPase activity, allowing cell chemotaxis and
aggregation to occur. cAMP-stimulated GTPase activities in pldB¯ cells and pldBOE cells
are not responsive to CMF. Phosphatidic acid and TOR are two possible signaling
molecules downstream of PldB in the CMF signal pathway, since addition of exogenous
phosphatidic acid or TOR-inhibiting rapamycin inhibits and promotes cell aggregation at
low cell density respectively.

Localized to cellular vesicles as well as cytoplasmic membrane, PldB is not only present
during early development when quorum sensing is occurring, but also in later
development. Besides the role in quorum sensing, pldB is involved in the timing of
development. cAMP receptor cAR1 is expressed earlier and at higher levels in pldB¯
cells than in wild-type cells, contributing to the rapid development phenotype of pldB¯
cells. However, pldB¯ cells have normal chemotaxis rate to cAMP. pldBOE cells lose
chemotactic ability, which may explain their non-aggregation phenotype.
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As a model organism, the discovery of a PLD enzyme in D. discoideum quorum sensing
pathways sheds light on the path to understanding quorum sensing mechanisms in
mammalian systems. Monitoring cell number while manipulating PLD activities would
be a feasible start. Moreover, our results indicate the involvement of a TOR-containing
multiprotein complex in quorum sensing pathways, as rapamycin disrupts quorum
sensing. This TOR complex is likely the one in charge of vegetative cell growth, i.e.
TORC1, thus disclosing a crosstalk between cell growth and quorum sensing pathways.
A similar mechanism is seen in mammalian cells. The type 1 insulin-like growth factor
receptor can send two seemingly contradictory signals, one for growth and one for
differentiation, depending on a balance between two of its substrates [102]. In our case,
TORC1 controls cell growth and also seems to mediate the quorum sensing pathway that
leads to cell development. This possible mechanism is feasible. When cells are in
vegetative growth and actively replicating, they do not aggregate or develop. This can be
explained by a high PldB activity, leading to a high TORC1 activity. This eventually
increases the GTPase activity of Gα2, inhibiting cAMP signaling. Thus, cells can not
aggregate or develop. When starving cells enter the development program, cell growth
stops. This can be explained by a low TORC1 activity caused by the presence of CMF
and consequently inhibited PldB activity. This decreases the GTPase activity of Gα2,
allowing cAMP signaling to occur. Cells can then aggregate and develop.

Although how TOR controls cell growth in D. discoideum has not been clarified,
mammalian TOR (mTOR) coordinates cell growth and proliferation by enabling mRNA
translation through three different downstream signal pathways [103]. One is that mTOR
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inhibits 4E binding protein 1 (4E-BP1), which then dissociates from eukaryotic initiation
factor 4E (eIF4E), making eIF4F complex formation possible. mRNA translation will
then be initiated. The second is that mTOR activates ribosomal protein S6 kinase 1
(S6K1), which then activates ribosomal protein S6 (rpS6), a component of 40S ribosome.
mRNA translation will then occur. The third is that mTOR inhibits eukaryotic elongation
factor 2 kinase (eEF2K). This keeps eEF2 active, which can mediate translation step of
peptide-chain elongation. A similar process may occur in D. discoideum.

Increased mRNA translation as a result of up-regulated mTOR activity has been strongly
suggested in the genesis of human cancers [95]. mTOR is activated by an upstream Ras
homolog enriched in brain (Rheb) protein, which is a mediator of nutrient signaling.
Rheb is inhibited by tuberous sclerosis complex (TSC1/2), which can be activated by
AMP-activated protein kinase (AMPK), a mediator of energy homeostasis. TSC1/2 can
also be inhibited by the growth factor insulin through PI3K/Akt pathway. Thus, the big
picture is that nutrients, energy and growth factors have a combined regulation of mTOR
and therefore mRNA translation. Mutations in tumor suppressors, such as PTEN
(reverses the PI3K signaling), LKB1 (activates AMPK to sense ATP depletion) and
TSC1/2, will result in constitutively activated mTOR. Since mTOR is required in cell
cycle progression and has anti-apoptotic activity [104, 105], constitutive mTOR activity
enables cancer cells to survive and proliferate.

Recently, phosphatidic acid, a product of PLD activity, has been reported to activate
mTOR as a way for cancer cells to overcome normal cellular responses to stress to
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continue proliferation [106]. Elevated PLD activity has been implicated in various human
cancers [107]. Similarly, our findings suggest that PldB may activate TOR in the quorum
sensing pathway of D. discoideum. This implies that the PLD regulation of mTOR is
possibly part of a quorum sensing mechanism. When cell size and number are below the
optimal level, PLD activity is high. mTOR is activated and mRNA translation occurs.
Cell cycle progression occurs. When cells reach the appropriate size and number, PLD
activity is low. mTOR is less activated and mRNA translation slows down. Cells may be
arrested at G1 phase and enter dormant G0 phase, or undergo apoptosis as needed. For
tumor or cancer cells, their compromised quorum sensing mechanisms either can not
sense the number of cells present or mistakenly sense a suboptimal level at all times.
These cells have constitutively high PLD activity, therefore constitutively activated
mTOR. Thus, cells keep increasing in size and number and will not go into dormancy or
apoptosis. Rapamycin competitively binds to the region of mTOR that interacts with
phosphatidic acid, preventing PLD activation of mTOR [108]. Therefore rapamycin
displays a tumor suppressing effect.

Overall, investigation of TOR, PLD and their upstream signals in mammalian quorum
sensing mechanisms is a promising direction for future research. This includes finding
out the subcellular localizations of these proteins and possible crosstalks with Rheb,
TSC1/2 and PI3K/Akt pathways. Our work in D. discoideum reveals multiple
physiological roles for PLD and beyond, providing a practical guide for research in
mammalian systems, thus leading to new therapeutic designs for human cancers and
other diseases.
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